Sublingual immunotherapy in children: the recent experiences

Area of Science:

• Allergy and Immunology
• Pediatric Medicine

Background:

• Allergic rhinitis and rhinoconjunctivitis affect many children.
• Environmental allergens like pollen and dust mites are common triggers.
• Sublingual immunotherapy (SLIT) is an alternative treatment option.

Purpose of the Study:

• To review recent studies on SLIT for pediatric environmental allergies.
• To compare SLIT's efficacy, safety, and immunological effects against other treatments.
• To examine data for ragweed, grass pollen, and dust mite allergies.

Main Methods:

• Review of recent and relevant scientific literature.
• Comparative analysis of SLIT versus subcutaneous immunotherapy, therapeutic treatments, and placebo.
• Examination of efficacy, safety, and immunological outcomes.

Main Results:

• SLIT demonstrated similar efficacy to subcutaneous immunotherapy in treating grass and dust mite allergies.
• SLIT was found to be a safer therapy with fewer anaphylaxis and local reactions.
• SLIT significantly improved symptom and medication scores compared to therapeutic treatments and placebo.

Conclusions:

• SLIT is a well-tolerated and effective treatment for pediatric allergic rhinitis and rhinoconjunctivitis.
• FDA-approved SLIT tablets are available for grass and ragweed allergies.
• This review provides valuable information for physicians seeking alternative pediatric allergy treatments.